TRASS: a global approach to assess the severity of truncal acne.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
07
12
2021
received:
30
07
2021
accepted:
07
01
2022
pubmed:
17
2
2022
medline:
14
5
2022
entrez:
16
2
2022
Statut:
ppublish
Résumé
Only a small amount of published data regarding truncal acne is available, and no proper tool to assess its severity exists. The aim of the study was to provide dermatologists with an easy-to-use tool to assess truncal acne (TRASS, truncal acne severity scale) using a global approach. A scoring tool that assesses the severity of acne (based on GEA and ECLA scales) on the trunk using a global approach was built, including three sub-scores: family history, clinical signs and quality of life (QoL). In order to test TRASS, the experts used photographs of 47 patients attending their clinics with truncal acne. The regression optimized (ROP) model was applied to assess the diagnosis performance of TRASS and to identify items contributing to the classification of the patients. Internal testing was made to demonstrate the robustness of the model. Correlation analyses between the different items were performed to evaluate the interaction between the different items and their impact on the severity grading of truncal acne. Patients with the most severe acne were identified by TRASS. The error level was 6.6% after internal validation and 10.4% when using the median value or the centile 75th (6.6% and 10.4%). Correlation was significant between systemic treatment and scars (P = 0.0025) and nodules (P = 0.01988) and between location and QoL (P = 0.0095). Truncal acne severity scale is the first global, patient-centred approach to evaluate truncal acne by scoring the importance of each factor independently from its clinical severity. TRASS may allow the practitioner to choose and validate the most suitable therapy together with the patient in order to treat his or her truncal acne successfully and to limit treatment failure.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
897-904Subventions
Organisme : Galderma International
Informations de copyright
© 2022 European Academy of Dermatology and Venereology.
Références
Nast A, Dreno B, Bettoli V et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26(Suppl 1): 1-29.
Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol 2013; 168: 474-485.
Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep 2020; 10: 5754.
Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol 2018; 32: 812-819.
Del Rosso JQ. Management of truncal acne vulgaris: current perspectives on treatment. Cutis 2006; 77: 285-289.
Tan JK, Tang J, Fung K et al. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol 2008; 7: 551-556.
Tan J, Thiboutot D, Popp G et al. Randomized phase 3 evaluation of trifarotene 50 mug/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol 2019; 80: 1691-1699.
Poli F, Auffret N, Leccia MT, Claudel JP, Dréno B. Truncal acne, what do we know? J Eur Acad Dermatol Venereol 2020; 34: 2241-2246.
Pillsbury DM, Shelley WB. Dermatology. Annu Rev Med 1954; 5: 363-388.
Burke BM, Cunliffe WJ. The assessment of acne vulgaris-the Leeds technique. Br J Dermatol 1984; 111: 83-92.
Dreno B, Bodokh I, Chivot M et al. ECLA grading: a system of acne classification for every day dermatological practice. Ann Dermatol Venereol 1999; 126: 136-141.
Tan JK, Tang J, Fung K et al. Development and validation of a comprehensive acne severity scale. J Cutan Med Surg 2007; 11: 211-216.
Tan J, Thiboutot D, Popp G et al. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol 2019; 80: 1691-1699.
Tan JK, Tang J, Fung K et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg 2010; 14: 156-160.
Bernardis E, Shou H, Barbieri JS et al. Development and initial validation of a multidimensional acne global grading system integrating primary lesions and secondary changes. JAMA Dermatol 2020; 156: 296-302.
Vilar GN, Santos LA, Sobral Filho JF. Quality of life, self-esteem and psychosocial factors in adolescents with acne vulgaris. An Bras Dermatol 2015; 90: 622-629.
Marron SE, Chernyshov PV, Tomas-Aragones L. Quality-of-life research in acne vulgaris: current status and future directions. Am J Clin Dermatol 2019; 20: 527-538.
Dreno B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol 2019; 33: 937-943.
McLellan C, Frey MP, Tan J. Assessing the need for a comprehensive acne quality-of-life scale for face and torso acne. J Cutan Med Surg 2018; 22: 263-266.
McLellan C, Frey MP, Thiboutot D, Layton A, Chren MM, Tan J. Development of a comprehensive quality-of-life measure for facial and torso acne. J Cutan Med Surg 2018; 22: 304-311.
LeBovidge J, Borok J, Udkoff J, Yosipovitch G, Eichenfield LF. Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care. Semin Cutan Med Surg 2017; 36 131-136.
Bowe W, Kober M. Therapeutic update: acne. J Drugs Dermatol 2014; 13: 235-238.
Blome C, Gosau R, Radtke MA et al. Patient-relevant treatment goals in psoriasis. Arch Dermatol Res 2016; 308: 69-78.
Common JEA, Barker JN, van Steensel MAM. What does acne genetics teach us about disease pathogenesis? Br J Dermatol 2019; 181(4): 665-676.
Rocha MA, Bagatin E. Adult-onset acne: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol 2018; 11: 59-69.
Hosthota A, Bondade S, Basavaraja V. Impact of acne vulgaris on quality of life and self-esteem. Cutis 2016; 98: 121-124.
Soliman YS, Horowitz R, Hashim PW, Nia JK, Farberg AS, Goldenberg G. Update on acne scar treatment. Cutis 2018; 102: 21; 5; 47; 8.
Stamu-O'Brien C, Jafferany M, Carniciu S, Abdelmaksoud A. Psychodermatology of acne: psychological aspects and effects of acne vulgaris. J Cosmet Dermatol 2021; 20: 1080-1083.
Dreno B, Poli F, Pawin H et al. Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol 2011; 25: 43-48.
Auffret N, Claudel JP, Leccia MT, Poli F, Farhi D, Dréno B. AFAST - Adult Female Acne Scoring Tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol 2016; 30: 824-828.
Steyerberg EW, Harrell FE, Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774-781.
Nguyen JM, Jézéquel P, Gillois P et al. Random forest of perfect trees: concept, performance, applications and perspectives. Bioinformatics 2021; 37: 2165-2174.
Jean-Michel N & Daniel A ROP: Regression Optimized: Numerical Approach for Multivariate Classification and Regression Trees, 2018. URL http://www.univ-nantes.fr/site-de-l-universite-de-nantes/jean-michel-nguyen--3564.kjsp (last accessed: 28 September 2021).
Del Rosso JQ, Bikowski JB, Baum E et al. A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol 2007; 6: 597-600.
Dreno B, Poli F. Epidemiology of acne. Dermatology 2003; 206: 7-10.
Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol 2009; 129: 2136-2141.
Karciauskiene J, Valiukeviciene S, Gollnick H, Stang A. The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a cross-sectional study. J Eur Acad Dermatol Venereol 2014; 28: 733-740.
Di Landro A, Cazzaniga S, Parazzini F et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012; 67: 1129-1135.
Aalemi AK, Anwar I, Chen H. Dairy consumption and acne: a case control study in Kabul, Afghanistan. Clin Cosmet Investig Dermatol 2019; 12: 481-487.
Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945-973.e33.
Nast A, Dreno B, Bettoli V et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol 2016; 30: 1261-1268.
Gupta A, Sharma YK, Dash KN, Chaudhari ND, Jethani S. Quality of life in acne vulgaris: relationship to clinical severity and demographic data. Indian J Dermatol Venereol Leprol 2016; 82: 292-297.
Acer E, Altınoz AE, Erdogan HK, Agaoglu E, Yuksel Canakcı N, Saracoglu ZN. Anxiety sensitivity and quality of life in patients with acne. Ann Dermatol 2019; 31: 372-377.
Tan JKL, Dirschka T. A new era for truncal acne: emerging from a legacy of neglect. Dermatol Ther (Heidelb) 2021; 11: 665-668.
Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-676.